Rank;Global Rank;Institution;Country;Sector
1;291;Hoffmann-La Roche, GmbH., Germany;DEU;Companies
2;314;Novartis Farma, S.p.A., Italy;ITA;Companies
3;343;Novo Nordisk A/S;DNK;Companies
4;401;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies
5;417;Hoffmann-La Roche, Ltd., Switzerland;CHE;Companies
6;421;Novartis, Switzerland;CHE;Companies
7;457;IMEC International;BEL;Companies
8;494;GlaxoSmithKline, United Kingdom;GBR;Companies
9;532;AstraZeneca, United Kingdom;GBR;Companies
10;600;Merck KGaA, Germany;DEU;Companies
11;736;Pfizer Inc., United Kingdom;GBR;Companies
12;843;Bayer AG, Germany;DEU;Companies
13;878;AstraZeneca, Sweden;SWE;Companies
13;878;SINTEF Group;NOR;Companies
15;910;GlaxoSmithKline, Belgium;BEL;Companies
16;1131;Sanofi-Aventis, Germany;DEU;Companies
17;1195;Eli Lilly and Company Ltd., United Kingdom;GBR;Companies
18;1235;Bruker Corp;DEU;Companies
19;1325;France Telecom, S.A.;FRA;Companies
20;1546;Telecom Italia S.p.A.;ITA;Companies
21;1573;Carl Zeiss AG;DEU;Companies
22;1752;BMW AG;DEU;Companies
23;2412;Robert Bosch GmbH;DEU;Companies
24;2759;Sincrotrone Trieste;ITA;Companies
25;2770;Renault, S.A.S.;FRA;Companies
26;2968;Fusion for Energy;ESP;Companies
27;3000;Daimler AG;DEU;Companies
28;3022;European XFEL GmbH;DEU;Companies
29;3236;Electricite de France, S.A.;FRA;Companies
30;3558;Intesa Sanpaolo S.p.A.;ITA;Companies
31;4924;Atomic Weapons Establishment;GBR;Companies
32;5019;ARUP;GBR;Companies
33;5170;BMJ Group;GBR;Companies